Artrya Limited
Research Artrya Limited (AYA.AX) on Bullrun: market cap AUD 449.47M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAYA.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyAUD
- Market capAUD 449.47M
- Financial periodFY2026
- RevenueAUD 28.00K
- Revenue growth0.0%
- Net income-AUD 25.18M
- Free cash flow-AUD 18.46M
- Gross margin100.0%
Valuation Snapshot
latest market cap is AUD 449.47M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 28.00K | -AUD 25.18M | -AUD 18.46M | 100.0% | n/a | AUD 44.03M | AUD 247.00K | AUD 78.29M |
| FY2025 | AUD 28.00K | -AUD 16.41M | -AUD 14.53M | 100.0% | -0.18 | AUD 11.33M | AUD 624.00K | AUD 21.29M |
| FY2024 | n/a | -AUD 14.00M | -AUD 15.41M | n/a | -0.18 | AUD 7.13M | AUD 949.00K | AUD 16.80M |
| FY2023 | n/a | -AUD 11.14M | -AUD 15.74M | n/a | -0.14 | AUD 20.13M | AUD 1.21M | AUD 30.56M |
| FY2022 | n/a | n/a | n/a | n/a | -0.26 | n/a | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-16 | AUD 449.47M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Artrya Limited
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Artrya Limited's market cap?
Artrya Limited's market capitalization is AUD 449.47M.
What does Artrya Limited do?
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.